Portal de Periódicos da CAPES

How Long Does Craving Predict Use of Methamphetamine? Assessment of Use One to Seven Weeks after the Assessment of Craving

2008; SAGE Publishing; Volume: 1; Linguagem: Inglês

10.4137/sart.s775

1178-2218

Gantt P. Galloway, Edward G. Singleton, M. Douglas Anglin, Richard A. Rawson, Marinelli-Casey Patricia, Balabis Joseph, Bradway Richard, Brown Alison Hamilton, Burke Cynthia, Christian Darrell, Cohen Judith, Cosmineanu Florentina, Dickow Alice, Donaldson Melissa, Frazier Yvonne, Thomas E. Freese, Gallagher Cheryl, Gantt P. Galloway, Gulati Vikas, H. James, H. Barry Kathryn, Huber Alice, Martin Y. Iguchi, Russell Lord, Michael McCann, Minsky Sam, Morrisey Pat, Obert Jeanne, Pennell Susan, Reiber Chris, Rodrigues Norman, S C Gomes Janice, P.H.S. Alex Stalcup, Ewa S. Stamper, Stimson Janice, Manser Sarah Turcotte, Vandersloot Denna, Weiner Ahndrea, Woodward Kathryn, Zweben Joan,

Forensic Toxicology and Drug Analysis

Aims This study lays the foundation for a clinical prediction model based on methamphetamine craving intensity and its ability to predict the presence or absence of within-treatment methamphetamine use. Design We used a random effects logistic approach for estimating repeated-measures, generalized linear mixed models (GLMM) using craving as the sole predictor of methamphetamine. A multivariate GLMM included craving, length of treatment, treatment assignment, and methamphetamine use the previous week as covariates to control for potential confounds. We performed receiver operating characteristic (ROC) analyses to evaluate predictive accuracy. We investigated further whether methamphetamine craving predicted subsequent use more accurately at intervals more proximal to versus those more distal to assessment, examining one-week periods ending one to seven weeks after assessment of craving. Setting The study was part of the Center for Substance Abuse Treatment (CSAT) Methamphetamine Treatment Project (MTP). Subjects Analyses were based on data from 691 methamphetamine dependent outpatients enrolled in the MTP. Measurements Craving was assessed by self-report on a 0–100 scale. Self-reported methamphetamine use was toxicologically verified. Craving and drug use were assessed weekly for 8 weeks. Findings In the univariate analysis craving predicted methamphetamine use in the week immediately following the craving report (p < 0.0001), with subject-specific use increasing 0.38% for each one-point increase in craving on a 0–100 scale. In the multivariate analysis the probability of use decreased by 2.45% for each week in treatment increased by 33.11% for previous methamphetamine use, and the probability of methamphetamine use still increased with craving, rising 0.28% for each one-point increase in craving score (all p < 0.0001). Predictive accuracy was strongest at the one-week time-lag and declined in magnitude the more distal the assessment period. Conclusions Craving is a predictor of within-treatment methamphetamine use. Intensity of craving is appropriate for use as a surrogate marker in methamphetamine dependence.